FREE EXPRESS SHIPPING ON AUSTRALIAN ORDERS OVER $150|SYDNEY, AUSTRALIA|RESEARCH USE ONLYFREE EXPRESS OVER $150|RESEARCH USE ONLY
Research Library›Comparisons›MOTS-c vs Humanin
Mitochondrial Comparison

MOTS-c vs Humanin: Comparing the Research

Two peptides discussed in mitochondrial signalling research, with different experiments and evidence limitations.

6 min read·4 studies cited·Updated September 2026
Quick Reference
Shared classMitochondrial-derived peptides
Humanin24 amino acids · identified 2001
MOTS-c16 amino acids · identified 2015
Humanin studied forCytoprotection, neuronal survival
MOTS-c studied forMetabolic regulation, AMPK signalling

What They Share

Both are discussed as mitochondrial-derived peptides. For Humanin, the 2001 correction limits the discovery paper’s claims about origin and natural production; classification should not be treated as proof of those points.

Compare evidence for a sequence, a production pathway and a biological effect separately. A finding about one peptide does not establish the same mechanism for the other.

Where They Differ

Humanin was identified in surviving brain tissue from an Alzheimer’s patient, and its research has centred on cytoprotection — cell survival under stress — particularly in neurons. Circulating levels decline with age.

MOTS-c has been studied chiefly in metabolic contexts. It activates AMPK, a central cellular energy sensor, and published work examines glucose uptake in muscle and fat metabolism. Several animal studies describe it as an exercise mimetic, reporting effects resembling some of those produced by physical activity.

Both fields are young and the literature is largely preclinical. Neither holds regulatory approval anywhere. Their greatest contribution so far has been conceptual — establishing that mitochondria participate in signalling rather than only in energy production.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated September 2026.

Browse the research range →

Published References

  1. Lee C, Zeng J, Drew BG, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell metabolism, 2015. PubMed
  2. Hashimoto Y, Niikura T, Tajima H, et al. “A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.” Proceedings of the National Academy of Sciences of the United States of America, 2001. PubMed
    The 2001 correction fixes an accession identifier and limits what the discovery paper established about genomic origin and in-vivo peptide production. It is not a verdict on subsequent research. View notice
  3. Lee C, Yen K, Cohen P. “Humanin: a harbinger of mitochondrial-derived peptides?” Trends in endocrinology and metabolism: TEM, 2013. PubMed
  4. Kim SJ, Xiao J, Wan J, et al. “Mitochondrially derived peptides as novel regulators of metabolism.” The Journal of physiology, 2017. PubMed

Research Use Only. All information on this site is provided for educational and laboratory research purposes only. Nothing on this site constitutes medical advice or a therapeutic claim.